The treatment landscape of triple-negative breast cancer
Medical Oncology · 29.08.2024 · 41 (10)
DOI: 10.1007/s12032-024-02456-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Oncology, online erschienen am 29.08.2024. Verfasst von Yi Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Gene Resource and Molecular Development, Beijing Normal University, Beijing, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Gene Resource and Molecular Development, Beijing Normal University, Beijing, China.
- Beijing Key Laboratory of Gene Resource and Molecular Development, Beijing Normal University, Beijing, China. lj@bnu.edu.cn.
- Beijing Key Laboratory of Gene Resource and Molecular Development, Beijing Normal University, Beijing, China. yangqiong@bnu.edu.cn.
Zitieren
APA
Hu, Y., Wang, C., Liang, H., Li, J., & Yang, Q. (2024). The treatment landscape of triple-negative breast cancer. Medical Oncology, 41(10). https://doi.org/10.1007/s12032-024-02456-9
Vancouver
Hu Y, Wang C, Liang H, Li J, Yang Q. The treatment landscape of triple-negative breast cancer. Medical Oncology. 2024;41(10). doi:10.1007/s12032-024-02456-9
BibTeX
@article{Hu2024,
author = {Hu, Yi and Wang, Chen and Liang, Huishi and Li, Jie and Yang, Qiong},
title = {The treatment landscape of triple-negative breast cancer},
journal = {Medical Oncology},
year = {2024},
volume = {41},
number = {10},
doi = {10.1007/s12032-024-02456-9}
}
EUVIMED